Neuro-Oncology

Susan Chang M.D.

University of California San Francisco
Clinical research: medical issues

 
Lisa DeAngelis M.D.

Memorial Sloan-Kettering Cancer Center
Clinical research: chemotherapy, clinical trials, medical issues

 
Henry Friedman M.D.

Duke University Medical Center
Clinical research: medical issues

 
Amar Gajjar M.D.

St. Jude Children's Research Hospital
Clinical research: clinical trials, medulloblastoma, late effects, molecular targeted therapies, pediatric neuro-oncology

 
Evanthia Galanis M.D.

Mayo Clinic
Targeted therapies, virotherapy/gene therapy

 
Mark Gilbert M.D.

University of Texas MD Anderson Cancer Center
Clinical and translational research, adult, primary brain tumors, chemotherapy, clinical trials

 
Richard Gilbertson M.D., Ph.D.

St. Jude Children's Research Hospital
Clinical research: pediatric neuro-oncology, early clinical trials, prognostic and correlative markers. Laboratory Research: Genomics, cancer stem cell biology, mouse models

 
Stuart Grossman M.D.

Johns Hopkins University
Clinical trials, new drug development

 
David Gutmann M.D., Ph.D.

Washington University School of Medicine
Genetically-engineered mice, preclinical models, signaling pathways, tumor microenvironment

 
Kurt Jaeckle, M.D.

Mayo Clinic
Clinical Research: medical oncology, gliomas, meningiomas,etc. Also any area involving metastatic CNS disease

 
Mark Kieran M.D., Ph.D.

Dana-Farber Cancer Institute
Clinical research: pediatric,antiangiogenesis therapies in brain tumors

 
John Laterra M.D., Ph.D

Johns Hopkins University School of Medicine
Clinical research: medical, targeted therapeutics. Laboratory research: cell signaling, cell death, cancer stem cells, angiogenesis, blood-brain barrier

 
Tobey MacDonald M.D.

Children's National Medical Center
Clinical research: pediatric neuro-oncology; Laboratory Research: Signal transduction, metastasis, angiogenesis

 
Tom Mikkelsen M.D.

Henry Ford Hospital Hermelin Brain Tumor Center
Clinical Research: Medical, molecular therapeutics, clinical trials, chemotherapy, neuroimaging. Laboratory Research: Invasion, pre-clinical therapeutics, neuroimaging, animal models

 
Brian O'Neill M.D.

Mayo Clinic
Primary CNS lymphoma, clinical interventions (e.g. neuroprotection), imaging

 
Michael Prados M.D.

University of California San Francisco
Clinical research, phase-1 and pilot phase-2

 
Lawrence Recht M.D.

Stanford University Medical Center
Clinical or experimental

 
Jeremy Rich M.D.

Duke University Medical Center
Cancer stem cells, Targeted therapies, Signal transduction, Invasion, Angiogenesis

David Schiff M.D.

University of Virginia Health Science Center

Clinical trials, chemotherapy, treatment-related toxicity, low-grade gliomas, glioblastoma, and PCNSL

 
Clinton Stewart Pharm.D.

St. Jude Children's Research Hospital
Neurooncology pharmacy. Clinical research: clinical pharmacology, drug development, developmental therapeutics, pharmacokinetics, pharmacogenomics, pediatric CNS tumors. Laboratory research: CNS drug penetration, pharmacokinetics, models, ABC transporters, multidrug resistance

 
Patrick Wen M.D.

Dana Farber Cancer Institute
Clinical research: medical, novel therapeutics, clinical trials

 
Cynthia Wetmore M.D., Ph.D.

Mayo Clinic

Please do not contact the reviewers directly.  Use the Grant Review Application.

To volunteer as a grant reviewer, please e-mail chas@soc-neuro-onc.org.